AzTrials
AzTrials

Hip Injuries and DisordersNCT06067243

Diagnostic Performance of 3T MRI T2 Mapping Technique in Chondro-labral Pathology of the Hip, Correlated With Intraoperative Arthroscopic Findings: Interventional Diagnostic Technique Validation Study (HPI MRI 3T)

An observational study of Hip Injuries and Disorders and Hip Arthrosis, run by Istituto Ortopedico Rizzoli at 1 site in Italy.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The goal of this observational study is to evaluate the diagnostic performance of the T2 mapping technique of the following 4 MRI scans in detecting hip chondro-labral lesions in comparison with intraoperative arthroscopic findings: 1) basal 3T MRI with T2 mapping technique, 2) 3T MRI with T2 mapping technique and… Read more about this study

Who is it for?
Ages 18 to 45 years
Conditions the study is for
Hip Injuries and Disorders, Hip Arthrosis
What is being tested?
T2 mapping 3T MRI + hip arthroscopy
How many people
0 participants
Where
1 siteItaly
Study dates
1 Jan 2024to 22 Jan 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: Young with symptomatic localized chondro-labral lesion requiring arthroscopic treatment

Who may be able to join

  • Patients with symptomatic localized chondro-labral lesion requiring arthroscopic treatment
  • Consent to conduct the study
  • BMI<30

Who cannot join

  • Patients unable to read or understand the patient information and consent forms;
  • Previous surgery on the same hip;
  • Coxarthrosis ≥ 2 according to Tonnis;
  • Acetabulum and/or proximal femur fractures;
  • Presence of psychological disorders, which might interfere with their ability to undergo the 4 MRI examinations;
  • Known sensitivity to gadolinium;
Show all 11Show fewer
  • BMI ≥ 30;
  • Current infections;
  • Tumors;
  • Metabolic disorders;
  • Presence of peripheral neurological disorders such as pudendal neuralgia, peroneal neuralgia, neuralgia sciatica that traction may risk worsening.

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Istituto Ortopedico Rizzoli

    Bologna, 40136

Other trials in Italy

About this study

Official title: Valutazione Della Performance Diagnostica di MRI 3T Con Tecnica T2 Mapping e Correlazione Intraoperatoria Artroscopica Nella Patologia Condro-labrale Dell'Anca: Studio Interventistico di Validazione di Tecniche Diagnostiche (HPI MRI 3T)

The goal of this observational study is to evaluate the diagnostic performance of the T2 mapping technique of the following 4 MRI scans in detecting hip chondro-labral lesions in comparison with intraoperative arthroscopic findings: 1) basal 3T MRI with T2 mapping technique, 2) 3T MRI with T2 mapping technique and limb traction; 3) 3T arthro-MRI with T2 mapping technique; 4) 3T arthro-MRI with T2 mapping technique and limb traction.

Read the detailed description

This study will evaluate the role of T2 mapping technique in the diagnosis of chondral and labral lesions of the hip. In particular, the following 4 types of MRI scan will be compared to each other and with intraoperative arthroscopic findings:

  • Basal 3T MRI without contrast
  • 3T MRI with limb traction
  • Arthro-RM 3T after intrarticular gadolinium and local anesthetic injection under ultrasound control
  • Arthro-RM 3T after intrarticular gadolinium and local anesthetic injection under ultrasound control + limb traction.

The primary endpoint is to:

  • assess the diagnostic performance of baseline 3T MRI with T2 mapping technique in terms of sensitivity, specificity, PPV, and NPV in the diagnosis of hip labral lesions, according to Philippon's classification, and chondral lesions according to modified Outerbridge classification,
  • compare the diagnostic performance between all the mentioned above scans.

The secondary endpoint is to evaluate the sensitivity, specificity, PPV and NPV of 3T MRI with longitudinal traction of the lower limb in detecting, localizing and grading chondral lesions of the coxo-femoral joint.

The present study will involve 30 young patients with coxalgia non responding to conservative treatment and referable to a chondro-labrum injury based on clinical and imaging examinations.

Patients will undergo RM diagnostic protocol and will receive hip arthroscopy within the next 6 months.

Being tested
T2 mapping 3T MRI + hip arthroscopy
Keywords
3T MRI, labral and chondral lesions, hip arthroscopy
Medical subject headings
Hip Injuries, Disease, Osteoarthritis, Hip

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • T2 mapping 3T MRI + hip arthroscopyDiagnostic test

    1. 3T MRI
    2. hip arthroscopy
Study groups in NCT06067243
Study groupRoleWhat they receive
HIP MRI-3 TYoung patients with coxalgia and clinical and imaging suspect for cartilage and/or labral lesion of the hip
Receives: Diagnostic Test: T2 mapping 3T MRI + hip arthroscopy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. T2 mapping 3T MRI

    • Grade of cartilage lesions according to modified Outerbridge classification;
    • Grade of labrum lesions according to Philippon's classification;
    • Localization of cartilage lesions according to the clock system;
    • Localization of labrum lesions by the ROI (Region Of Interest) method.

    Measured: At baseline (Day 0)

  2. Hip arthroscopy

    • Grade of cartilage lesions according to modified Outerbridge classification;
    • Grade of labrum lesions according to Philippon's classification;
    • Localization of cartilage lesions according to the clock system;
    • Localization of labrum lesions by the ROI (Region Of Interest) method.

    Measured: Within 6 months from day 0

  3. Data comparison

    In the postoperative phase, the intraoperative findings will be compared with the preoperative findings of the 4 MRI types by proceeding to calculate their sensitivity, specificity, PPV, NPV in relation to the degree and location of chondro-labral lesions of the hip.

    Measured: Within 21 months from beginning of the study

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Oct 2023
  2. Study start1 Jan 2024
  3. Primary completion22 Jan 2024
  4. Study completion22 Jan 2024

Why it stopped: No patients

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06067243
Sponsor's protocol ID
CE-AVEC 577/2020/Sper/IOR
Status last verified
Mar 2024
First submitted
5 Sep 2023
Last updated
20 Mar 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Hip Injuries and Disorders and Hip Arthrosis, run by Istituto Ortopedico Rizzoli at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 20 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

T2 mapping 3T MRI (time frame: At baseline (Day 0)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in